| Year |
Citation |
Score |
| 2024 |
Silver AJ, Brown DJ, Olmstead SD, Watke JM, Gorska AE, Tanner L, Ramsey HE, Savona MR. Repair of leukemia-associated single nucleotide variants via interallelic gene conversion. Biorxiv : the Preprint Server For Biology. PMID 38659776 DOI: 10.1101/2024.04.16.587991 |
0.575 |
|
| 2024 |
Shannon ML, Heimlich JB, Olson S, Debevec A, Copeland Z, Kishtagari A, Vlasschaert C, Snider CA, Silver AJ, Brown D, Spaulding TP, Bhatta MR, Pugh K, Stockton SS, Ulloa J, et al. Clonal Hematopoiesis and Inflammation in the VasculaturE (CHIVE): a prospective, longitudinal cohort and biorepository. Blood Advances. PMID 38608257 DOI: 10.1182/bloodadvances.2023011510 |
0.554 |
|
| 2024 |
Mack T, Vlasschaert C, von Beck K, Silver AJ, Heimlich JB, Poisner H, Condon HR, Ulloa J, Sochacki AL, Spaulding TP, Kishtagari A, Bejan CA, Xu Y, Savona MR, Jones A, et al. Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics. The Journal of Molecular Diagnostics : Jmd. PMID 38588769 DOI: 10.1016/j.jmoldx.2024.03.007 |
0.73 |
|
| 2024 |
Silver AJ, Vlasschaert C, Mack T, Sharber B, Xu Y, Bick AG, Pinson CW, Savona MR. Solid organ transplant recipients exhibit more TET2-mutant clonal hematopoiesis of indeterminate potential not driven by increased transplantation risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38551504 DOI: 10.1158/1078-0432.CCR-23-3840 |
0.48 |
|
| 2024 |
Heimlich JB, Bhat P, Parker A, Jenkins MT, Vlasschaert C, Ulloa J, Van Amburg J, Potts CR, Olson S, Silver AJ, Ahmad A, Sharber B, Brown D, Hu N, van Galen P, et al. Multiomic Profiling of Human Clonal Hematopoiesis Reveals Genotype and Cell-Specific Inflammatory Pathway Activation. Blood Advances. PMID 38507736 DOI: 10.1182/bloodadvances.2023011445 |
0.567 |
|
| 2024 |
Monteith AJ, Ramsey HE, Silver AJ, Brown D, Greenwood D, Smith BN, Wise AD, Liu J, Olmstead SD, Watke J, Arrate MP, Gorska AE, Fuller L, Locasale JW, Stubbs MC, et al. Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia. Cancer Research. PMID 38285895 DOI: 10.1158/0008-5472.CAN-23-0291 |
0.602 |
|
| 2024 |
Kishtagari A, Khan MAW, Li Y, Vlasschaert C, Marneni N, Silver AJ, von Beck K, Spaulding T, Stockton S, Snider C, Sochacki A, Dorand D, Mack TM, Ferrell PB, Xu Y, et al. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood Cancer Journal. 14: 6. PMID 38225345 DOI: 10.1038/s41408-023-00974-9 |
0.736 |
|
| 2023 |
Mack T, Vlasschaert C, von Beck K, Silver AJ, Heimlich JB, Poisner H, Condon HR, Ulloa J, Sochacki AL, Spaulding TP, Kishtagari A, Bejan CA, Xu Y, Savona MR, Jones A, et al. Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics. Medrxiv : the Preprint Server For Health Sciences. PMID 37986782 DOI: 10.1101/2023.11.08.23298270 |
0.727 |
|
| 2023 |
Vlasschaert C, Mack T, Heimlich JB, Niroula A, Uddin MM, Weinstock JS, Sharber B, Silver AJ, Xu Y, Savona MR, Gibson CJ, Lanktree MB, Rauh MJ, Ebert BL, Natarajan P, et al. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets. Blood. PMID 36652671 DOI: 10.1182/blood.2022018825 |
0.551 |
|
| 2022 |
Sochacki AL, Bejan CA, Zhao S, Patel A, Kishtagari A, Spaulding TP, Silver AJ, Stockton SS, Pugh K, Dorand RD, Bhatta MR, Strayer N, Zhang S, Snider CA, Stricker TP, et al. Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. Blood Advances. PMID 35420683 DOI: 10.1182/bloodadvances.2021006318 |
0.705 |
|
| 2022 |
Jasra S, Giricz O, Zeig-Owens R, Pradhan K, Goldfarb DG, Barreto-Galvez A, Silver AJ, Chen J, Sahu S, Gordon-Mitchell S, Choudhary GS, Aluri S, Bhagat TD, Shastri A, Bejan CA, et al. High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nature Medicine. PMID 35256801 DOI: 10.1038/s41591-022-01708-3 |
0.572 |
|
| 2021 |
Silver AJ, Bick AG, Savona MR. Publisher Correction: Germline risk of clonal haematopoiesis. Nature Reviews. Genetics. PMID 34140664 DOI: 10.1038/s41576-021-00384-2 |
0.47 |
|
| 2021 |
Silver AJ, Bick AG, Savona MR. Germline risk of clonal haematopoiesis. Nature Reviews. Genetics. PMID 33986496 DOI: 10.1038/s41576-021-00356-6 |
0.563 |
|
| 2019 |
Silver AJ, Jaiswal S. Clonal hematopoiesis: Pre-cancer PLUS. Advances in Cancer Research. 141: 85-128. PMID 30691686 DOI: 10.1016/Bs.Acr.2018.12.003 |
0.395 |
|
| 2019 |
Sochacki A, Zhao S, Bejan CA, Spaulding T, Stockton S, Silver A, Dorand D, Zhang S, Stricker T, Xu Y, Savona MR. JAK2V617F Clonal Hematopoiesis Stratifies By Peripheral Blood Counts. Blood. 134: 1203-1203. DOI: 10.1182/Blood-2019-129639 |
0.701 |
|
| 2019 |
Spaulding T, Strayer N, Sochacki A, Stockton S, Silver A, Dorand RD, Zhang S, Lin Y, Xu Y, Savona MR. Patient-Specific Risk Factors Independently Influence Survival in Myelodysplastic Syndromes in an Unbiased Review of EHR Records Blood. 134: 5440-5440. DOI: 10.1182/Blood-2019-122400 |
0.562 |
|
| 2019 |
Sochacki A, Bejan CA, Zhao S, Spaulding T, Stockton S, Silver A, Dorand D, Zhang S, Stricker T, Xu Y, Savona MR. Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis Blood. 134: 2959-2959. DOI: 10.1182/Blood-2019-121513 |
0.605 |
|
| 2018 |
Kahn JD, Miller PG, Silver AJ, Sellar RS, Bhatt S, Gibson C, McConkey M, Adams D, Mar B, Mertins P, Fereshetian S, Krug K, Zhu H, Letai A, Carr SA, et al. PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. PMID 29954749 DOI: 10.1182/Blood-2018-05-850339 |
0.343 |
|
| Show low-probability matches. |